A phase III trial to test the safety and efficacy of two doses of aripiprazole in child and adolescent patients with bipolar I disorder, manic, or mixed episode with or without psychotic features

Trial Profile

A phase III trial to test the safety and efficacy of two doses of aripiprazole in child and adolescent patients with bipolar I disorder, manic, or mixed episode with or without psychotic features

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Mar 2013

At a glance

  • Drugs Aripiprazole (Primary)
  • Indications Bipolar I disorders
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 01 Oct 2009 Results published in the Journal of Clinical Psychiatry.
    • 30 Aug 2008 Results presented at ECNP 2008.
    • 31 Aug 2006 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top